Cigna Group $CI Stock Holdings Decreased by KBC Group NV

KBC Group NV lessened its stake in Cigna Group (NYSE:CI) by 0.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 357,056 shares of the health services provider’s stock after selling 2,180 shares during the quarter. KBC Group NV’s holdings in Cigna Group were worth $95,245,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Wilkerson Advisory Group LLC bought a new stake in Cigna Group in the fourth quarter valued at about $25,000. Beacon Financial Strategies CORP acquired a new stake in Cigna Group during the fourth quarter valued at approximately $28,000. Cedar Mountain Advisors LLC lifted its holdings in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group in the 4th quarter worth approximately $29,000. Finally, Prosperity Bancshares Inc acquired a new position in shares of Cigna Group in the 4th quarter worth approximately $29,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CI. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Morgan Stanley lifted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research note on Friday, May 1st. UBS Group increased their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Finally, Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Stock Up 0.1%

Cigna Group stock opened at $281.72 on Monday. The company has a 50-day simple moving average of $286.68 and a 200-day simple moving average of $280.43. The firm has a market capitalization of $74.52 billion, a P/E ratio of 11.94, a P/E/G ratio of 1.08 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s payout ratio is 26.45%.

Insider Activity at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.